# eniferBio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/eniferbio

- Industry: Biotechnology
- Headquarters: Espoo, Finland
- Website: www.enifer.com
- Total disclosed funding: $30M
- Latest round: Series B (May 23, 2024)
- Investors on record: 6

## About

Based in Finland, and founded in 2020 by its CEO, Simo Ellilä, Business Development Manager, Heikki Keskitalo, COO, Joosu Kuivanen, CSO, Anssi Rantasalo, and Chief Engineering Officer, Ville Pihlajaniemi, eniferBio eniferBio Oy, operates as a biotechnology company that offers mycoprotein powder made from single-cell protein derived from fungi. In April 2023, eniferBio raised EUR 11 million in series A funding co-led by investors Aqua-Spark and Finnish Industry Investment Tesi, along with returning investor Valio Ltd, with participation from other returning investors, Nordic Foodtech VC. The company offers PEKILO®, a mycoprotein powder, dried powder protein used as pet food, and aquafeed upcycle by-products from diverse agri-food, and forest industry processes. The company uses an integrated production process for PEKILO® P65 product consisting of 65% crude protein, and a balanced amino acid profile. The company plans to use the April 2023 funding to scale up its production and seek approvals for its products.

## Funding rounds

- Series B, May 23, 2024, $16M — Voima Ventures, Nordic Foodtech VC, Taaleri Bioindustry, Valio Ltd
- Series A, Apr 18, 2023, $12M — Tesi, Aqua-Spark, Voima Ventures, Nordic Foodtech VC, Valio Ltd
- Seed, Oct 30, 2020, $1.2M — Voima Ventures, Nordic Foodtech VC

## Investors

- Voima Ventures (https://capitalatlas.ai/funds/voima-ventures) — Seed, Series A, Series B
- Nordic Foodtech VC (https://capitalatlas.ai/funds/nordic-foodtech-vc) — Seed, Series A, Series B
- Tesi (https://capitalatlas.ai/funds/tesi) — Series A
- Aqua-Spark (https://capitalatlas.ai/funds/aqua-spark) — Series A
- Valio Ltd — Series A, Series B
- Taaleri Bioindustry (https://capitalatlas.ai/funds/taaleri-bioindustry) — Series B